{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:00:37Z","timestamp":1790744437436,"version":"4.1.0"},"reference-count":10,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Concurrent chemoradiotherapy (CCRT) combined with pembrolizumab has become the standard treatment for high-risk locally advanced cervical cancer, increasing the need for prompt recognition of immune-related adverse events (irAEs). We report a rare case of severe gastrointestinal irAE complicated by hepatic portal venous gas (HPVG) during pembrolizumab-based CCRT. A 72-year-old woman with FIGO 2018 stage IIIC1r cervical squamous cell carcinoma developed persistent diarrhea and anorexia during treatment, followed by sudden hematemesis after the first brachytherapy session. Upper gastrointestinal endoscopy revealed diffuse gastric mucosal necrosis, while contrast-enhanced computed tomography demonstrated HPVG, intramural gastric gas, and diffuse gastrointestinal wall edema without evidence of intestinal ischemia. Gastric biopsy showed marked intraepithelial lymphocytic infiltration predominantly composed of CD8-positive T cells, consistent with pembrolizumab-induced gastrointestinal irAE. High-dose corticosteroid therapy and supportive conservative management resulted in rapid clinical and radiological resolution, avoiding surgical intervention. This case highlights that gastrointestinal irAEs may mimic conventional CCRT-related toxicities, delaying diagnosis. Furthermore, HPVG should not be considered synonymous with intestinal necrosis. Careful integration of clinical, radiological, endoscopic, and pathological findings is essential to distinguish immune-mediated gastrointestinal injury from ischemic disease and to guide appropriate management.<\/jats:p>","DOI":"10.3389\/fonc.2026.1942174","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:45:20Z","timestamp":1790743520000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful conservative management of hepatic portal venous gas complicating severe immune-related gastrointestinal injury during pembrolizumab-based concurrent chemoradiotherapy for cervical cancer: a mechanistic case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Miwa","family":"Minamitani","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Tsuyoshi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsushi","family":"Naito","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Nakamoto","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Orisaka","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(24)01808-7","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"404","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"Management of toxicities from immunotherapy: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen","year":"2022","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v30.i14.1941","article-title":"Immune checkpoint inhibitor-associated gastritis: patterns and management","volume":"30","author":"Lin","year":"2024","journal-title":"World J Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v17.i10.109062","article-title":"Advancement in the diagnosis and treatment of hepatic portal venous gas","volume":"17","author":"Zhou","year":"2025","journal-title":"World J Gastrointest Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.70352\/scrj.cr.25-0603","article-title":"A case of unresectable advanced esophageal cancer with recurrent pneumatosis intestinalis and portal venous gas during chemotherapy with immune checkpoint inhibitors","volume":"11","author":"Tashiro","year":"2025","journal-title":"Surg Case Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5858\/arpa.2019-0700-oa","article-title":"Immune checkpoint inhibitor-induced upper gastrointestinal tract inflammation shows morphologic similarities to, but is immunologically distinct from, Helicobacter pylori gastritis and celiac disease","volume":"145","author":"Irshaid","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-020-01206-4","article-title":"Mesenteric ischemia with pneumatosis intestinalis and portal vein gas associated with enteral nutrition: a series of three patients","volume":"13","author":"Matsuoka","year":"2020","journal-title":"Clin J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318032c473","article-title":"Pneumatosis intestinalis: a challenging biopsy diagnosis","volume":"31","author":"Koreishi","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.06.1309","article-title":"Pneumatosis intestinalis in the adult: benign to life-threatening causes","volume":"188","author":"Ho","year":"2007","journal-title":"AJR Am J Roentgenol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1942174\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:45:38Z","timestamp":1790743538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1942174\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":10,"alternative-id":["10.3389\/fonc.2026.1942174"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1942174","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1942174"}}